Mergers & Acquisitions ·
Cardiff Lexington agrees to acquire multi-location musculoskeletal platform for up to $104M
CDIXCardiff Lexington Corp
Cardiff Lexington Corporation announced a letter of intent to acquire a multi-location musculoskeletal healthcare platform for up to $104 million. The consideration includes $30 million in cash, $10 million in unsecured notes, preferred equity granting sellers 35% post-closing ownership, and up to $12 million in common stock contingent on EBITDA targets of $15M, $18M, and $22M for 2027-2029. The transaction aims to expand the company's integrated regional healthcare operations combining orthopedics, spine care, and ancillary services. Closing is projected for November 16, 2026, subject to due diligence and financing. Cardiff Lexington Corporation operates as a healthcare holding company focused on acquiring and developing businesses in orthopedics, spine care, pain management, and related healthcare services.